ArticleAdvanced healthcare materials2025
Using High-Throughput Screening to Identify Crosslinking Peptides That Control Cell-Mediated Matrix Degradation.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Design and Synthesis of Peptide-Polyester Conjugates for Cell-Mediated Scaffold Degradation.Advanced healthcare materials · 2026Article
- Tuning scaffold degradation with non-natural peptidomimetics to control human umbilical vein endothelial cell morphology and vessel formation.Acta biomaterialia · 2026Article
- The Intersecting Physical Mechanisms That Regulate Cell Viability in 3D Synthetic Hydrogels.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Structure-Property-Function Relationships in Stimuli-Responsive Hydrogels for Brain Organoid Vascularization.Gels (Basel, Switzerland) · 2026Review
- Peptide Arrays as Tools for Unraveling Tumor Microenvironments and Drug Discovery in Oncology.Cells · 2026Review
- Using High-Throughput Screening to Identify Crosslinking Peptides That Control Cell-Mediated Matrix Degradation.Advanced healthcare materials · 2025Article
- Tuning Scaffold Degradation with Non-Natural Peptidomimetics to Control Human Umbilical Vein Endothelial Cell Morphology and Vessel Formation.bioRxiv : the preprint server for biology · 2025Article
- Design and Synthesis of Peptide-Polyester Conjugates for Cell-Mediated Scaffold Degradation.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cells modify the extracellular matrix by expressing proteases that degrade matrix proteins, enabling cell migration within tissues. This process is mimicked in hydrogels through protease-degradable peptide crosslinks. However, cleaving hydrogel crosslinks reduces local matrix mechanical properties, and most crosslinking peptides, including the widely used GPQGIWGQ "PanMMP" sequence, often lead to bulk hydrogel degradation. Membrane-type proteases are localized to the cell surface, have important roles in cell migration, and are active in the pericellular region. To identify peptides primarily cleaved by membrane-type proteases, an approach is developed that couples proteomic identification of candidate peptides with mass spectrometry-based functional assays to quantify degradation. The target sequence is then optimized using a split-and-pool synthesis to generate over 300 peptide variants to improve degradation behavior. The optimized peptide, KLVADLMASAE, shows reduced degradation by soluble proteases, while enabling endothelial and stem cell spreading and viability comparable to PanMMP hydrogels. KLVADLMASAE-crosslinked hydrogels have reduced crosslinker degradation, are stiffer during culture, and exhibit less macroscopic degradation after 14 days of culture than PanMMP gels. The performance of KLVADLMASAE-crosslinked gels is significantly improved from the initial peptide target, validating this functional high-throughput approach for identifying peptides that control matrix degradation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.